Buch, Englisch, 400 Seiten, Format (B × H): 159 mm x 236 mm, Gewicht: 667 g
Hemophilia and the Unintended Consequences of Medical Progress
Buch, Englisch, 400 Seiten, Format (B × H): 159 mm x 236 mm, Gewicht: 667 g
ISBN: 978-1-4214-0115-7
Verlag: Johns Hopkins University Press
This is both a success story and a cautionary tale, one built on the emergence in the 1950s and 1960s of an advocacy movement that sought normalcy—rather than social isolation and hyper-protectiveness—for the boys and men who suffered from the severest form of the disease.
Stephen Pemberton evokes the allure of normalcy as well as the human costs of medical and technological progress in efforts to manage hemophilia. He explains how physicians, advocacy groups, the blood industry, and the government joined patients and families in their unrelenting pursuit of normalcy—and the devastating, unintended consequences that pursuit entailed. Ironically, transforming the hope of a normal life into a purchasable commodity for people with bleeding disorders made it all too easy to ignore the potential dangers of delivering greater health and autonomy to hemophilic boys and men.
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Hämatologie, Transfusionsmedizin
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Public Health, Gesundheitsmanagement, Gesundheitsökonomie, Gesundheitspolitik
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Geschichte der Medizin
Weitere Infos & Material
Preface
Acknowledgments
Introduction: Hemophilia as Pathology of Progress
1. The Emergence of the Hemophilia Concept
2. The Scientist, the Bleeder, and the Laboratory
3. Vital Factors in the Making of a Masculine World
4. Normality within Limits
5. The Hemophiliac's Passport to Freedom
6. Autonomy and Other Imperatives of the Health Consumer
7. The Mismanagement of Hemophilia and AIDS
Conclusion: The Governance of Clinical Progress in a Global Age
Notes
Index